Rekah Pharmaceutical Products Ltd in Consumer Health (Israel)

July 2013 | 3 pages | ID: R285120D4B1EN
Euromonitor International Ltd

Abstracts

In 2012 the company sets financial goals and in order to reach them it is planning to invest most of the profits it makes in enlarging its facilities The goals set by the company in 2011 were achieved and the company reported an increase in its Rx production.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Rekah Pharmaceutical Industries Ltd: Key Facts
Summary 2 Rekah Pharmaceutical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Rekah Pharmaceutical Products Ltd: Competitive Position 2012